TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pro Health Pharma Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
14,497
|
12,960 | |
| Financial expenses |
113
|
5 | |
| Earnings before taxes |
445
|
754 | |
| EBITDA |
557
|
1,093 | |
| Total assets |
11,024
|
8,488 | |
| Current assets |
9,202
|
7,423 | |
| Current liabilities |
4,239
|
2,079 | |
| Equity capital |
6,649
|
6,274 | |
| - share capital |
67
|
67 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
60.3%
|
73.9% | |
| Turnover per employee |
4,832
|
4,320 | |
| Profit as a percentage of turnover |
3.1%
|
5.8% | |
| Return on assets (ROA) |
5.1%
|
8.9% | |
| Current ratio |
217.1%
|
357.0% | |
| Return on equity (ROE) |
6.7%
|
12.0% | |
| Change turnover |
1,470
|
1,016 | |
| Change turnover % |
14%
|
11%
|
9% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.